Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction

   Introduction. Cigarette smoking along with alcohol consumption, infection with human papilloma (HPV) and the Epstein–Barr viruses, is one of the main risk factors for head and neck squamous cell carcinoma. It can also contribute to virus-associated carcinogenesis and affect the clinical and prognostic features of the tumor. Continued smoking at diagnosis of head and neck squamous cell carcinoma is a negative prognostic factor and contributes to reduced patient survival rates.

   Aim. To analyze the smoking status and the effect of etiopathogenesis on molecular and clinical features in patients with oropharyngeal squamous cell carcinoma (OpSCC).

   Materials and methods. In patients with OPSCC, the smoking status and the level of motivation to its cessation were clarified. Immunohistochemical analysis of tumor sections from paraffin blocks from the ThermoScentific immunohis-tosteiner was performed using monoclonal antibodies to estrogen receptors α (ERα), programmed death-ligand 1 (pD-L1), Bcl-2, p53 and p16. The percentage of tumor-infiltrating lymphocytes (TILs) in the stromal component of the tumor (hematoxylin and eosin staining) was also analyzed.

   Results. Of 113 patients with OpSCC, 80 % of patients were current smokers, including 75 % of patients with Hpv-positive tumor status. men with OpSCC were statistically significantly more likely to smoke than women (p = 0.001), as were men with Hpv-positive tumor (p = 0.015). Smoking patients were characterized by a larger size of the primary tumor (T3–4), including those with Hpv (p = 0.015). positive Hpv status of the tumor is associated with autoimmune diseases (autoimmune thyroiditis, psoriasis) (p ˂ 0.05). A high level of TILs is characteristic of smokers, including those with p16+-status (p ˂0.05), but not for all patients with this status. The positive expression of ERα is associated with p16+-status, and the latter is associated with the absence of p53 expression (p ˂0.05). During conservative therapy, tumor regression is associated with the primary tumor size T1–2, p16 + status, female sex, age less than 55 years, TILs level ≥ 57.5 %, pD-L1 expression levels on tumor cells ≥2.2 %, Bcl-2 ≥5 % and ERα ≥65 % (p ˂ 0.05). At the same time, quality of good predictive model for tumor regression showed a TILs level of ≥57.5 % (area under curve, AuC) 0.796; sensitivity 78.6 %; specificity 75 %) and ERα (AuC 0.725; sensitivity 65 %; specificity 83 %). The level of motivation to quit smoking ranged from 1 to 7 points according the 10-point motivation scale in 89 % of respondents. Only 10 patients were ready to quit smoking immediately (10 points on the motivation scale).

   Conclusion. Molecular heterogeneity of OPSCC was revealed, including in the group of p16+-tumors. Correlation of clinical and molecular parameters with response to conservative therapy can be used in planning of primary therapy and earlier use of surgical treatment. The level of motivation to quit smoking in patients with squamous cell carcinoma of the head and neck may be increased by drawing attention to the problem at each doctor’s appointment as well as by informing about how to quit smoking and therapeutic approaches. In unmotivated patients, the concept of reducing the harm of smoking can be used involving the replacement of cigarettes with electronic tobacco heating systems, eliminating the carcinogenic effect of its combustion products.

1. Pemberton M. Oral cancer and tobacco: developments in harm reduction. Br Dent J 2018;225:822–6. DOI: 10.1038/sj.bdj.2018.928

2. Von Kroge P.R. The impact of smoking cessation and continuation on recurrence and survival in patients with head and neck cancer : a systematic review of the literature. Oncol Res Treat 2020;43(10):549–57. DOI: 10.1159/000509427

3. Sobus S.L., Warren G.W. The biologic effects of cigarette smoke on cancer cells. Cancer 2014;120(23):3617–26. DOI: 10.1002/cncr.28904

4. Warren G.W., Singh A.K. Nicotine and lung cancer. J Carcinog 2013;12:1. DOI: 10.4103/1477-3163.106680

5. O’Malley M., King A.N., Conte M. et al. Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer. J Thorac Oncol 2014;9(7):917–26. DOI: 10.1097/JTO.0000000000000191

6. Petros W.P., Pharm D., Younis I.R. et al. Effects of tobacco smoking and nicotine on cancer treatment. Pharmacotherapy 2012;32(10):920–31. DOI: 10.1002/j.1875-9114.2012.01117

7. Iocca O., Farcomeni A., Di Rocco A. et al. Locally advanced squamous cell carcinoma of the head and neck : A systematic review and Bayesian network meta-analysis of the currently available treatment options. Oral Oncol 2018;80:40–51. DOI: 10.1016/j.oraloncology.2018.03.001

8. Caini S., Del Riccio M,, Vettori V. et al. Post-diagnosis smoking cessation and survival of patients with head and neck cancer : a systematic review and meta-analysis. Br J Cancer 2022;127(11):1907–15. DOI: 10.1038/s41416-022-01945-w

9. Sacks R.L., Cui Y., Karam-Hage M. et al. Impact of smoking cessation in locally advanced head and neck cancers undergoing radiation. J Clin Oncol 2019;37(15). DOI: 10.1200/JCO.2019.37.15_suppl.6068.

10. Smith J., Nastasi D., Tso R. et al. The effects of continued smoking in head and neck cancer patients treated with radiotherapy : а systematic review and meta-analysis. Radiotherapy and On cology 2019;135:51–7. DOI: 10.1016/j.radonc.2019.02.021

11. Jassem J. Tobacco smoking after diagnosis of cancer: clinical aspects. Transl Lung Cancer Res 2019;8(1):50–8. DOI: 10.21037/tlcr.2019.04.01

12. Carrillo-Beltrán D., Silva-Pavez E., Carrillo-Beltrán D., Calaf G.M. Interaction between cigarette smoke and human papillomavirus 16 E6/E7 oncoproteins to induce SOD2 expression and DNA damage in head and neck cancer. Int J Mol Sci 2023;24:6907. DOI: 10.3390/ijms24086907

13. Stukan A.I., Murashko R.A., Tsygan N.A. et al. Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender. Opukholi golovy i shei = Head and Neck Tumors 2022;12(3):114–26. (In Russ.). DOI: 10.17650/2222-1468-2022-12-3-114-126

14. Tobillo R., De Joya E., Dooley S. et al. Female sex and increased immune marker mRNA gene expression are associated with decreased overall survival in patients with HPV-negative head and neck cancer. Int J Rad Oncol Biol Phys 2021;111(3S):e238–9. DOI: 10.1016/j.ijrobp.2021.07.810

15. Stukan A.I., Chukhray O.Yu., Maksimenko S.D. The importance of etiopathogenesis in the formation of a local immune responsein squamous cell oropharyngeal cancer. Voprosy onkologii = Oncology Issues 2023;69(2):300–7. (In Russ.). DOI: 10.37469/0507-3758-2023-69-2-300-307

16. Kano M., Kondo S., Wakisaka N. et al. Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer. Int J Cancer 2019;145(6):1547–57. DOI: 10.1002/ijc.32500

17. Evans W.K. Implementing smoking cessation within cancer treatment centres and potential economic impacts Transl Lung Cancer Res 2019;8(1):S11–20. DOI: 10.21037/tlcr.2019.05.09

18. Sampson L., Papadakos J., Milne V. et al. Preferences for the provision of smoking cessation education among cancer patients. J Cancer Educ 2018;33(1):7–11. DOI: 10.1007/s13187-016-1035-0

19. Yong H.H., Borland R., Balmford J. et al. Heaviness of smoking predicts smoking relapse only in the first weeks of a quit attempt: findings from the International Tobacco Control Four-Country Survey. Nicotine Tob Res 2014;16(4):423–9. DOI: 10.1093/ntr/ntt165

20. Conlon M.S.C., Santi S.A., Meigs M.L. et al. Cigarette-smoking characteristics and interest in cessation in patients with head-and-neck cancer. Curr Oncol 2020;27(5):e476–85. DOI: 10.3747/co.27.6019

21. Krutza M., Acharya P., Chissoe G. et al. Tobacco cessation after head and neck cancer diagnosis is an independent predictor of treatment response and long-term survival. Oral Oncol 2022:134:106172. DOI: 10.1016/j.oraloncology.2022.106072

22. McQueen N., Partington E.J., Harrington K.F. et al. Smoking cessation and electronic cigarette use among head and neck cancer patients. Otolaryngol Head Neck Surg 2016;154(1):73–9. DOI: 10.1177/0194599815613279

23. McCarter K., Martínez Ú., Britton B. et al. Smoking cessation care among patients with head and neck cancer : a systematic review. BMJ Open 2016;6:e012296. DOI: 10.1136/bmjopen-2016-012296

24. Conlon M.S.C., Santi S.A., Meigs M.L. et al. Cigarette-smoking characteristics and interest in cessation in patients with head-and-neck cancer Curr Oncol 2020;27(5)e478–85. DOI: 10.3747/co.27.6019

25. Rzepakowska А., Marcinkiewicz B., Żurek M. Motivation to smoking cessation in head and neck cancer and dysplasia patients in confrontation with the attitudes of otorhinolaryngologists in delivering anti-smoking therapies. Eur Arc Otorhinolaryngol 2022;279(7):3645–55. DOI: 10.1007/s00405-021-07209-2

26. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Smoking Cessation. Available at: https://www.nccn.org/professionals/physician_gls/pdf/smoking.pdf.

27. Bielecka N.P., Bielicka S., Lewkowicz N. et al. Effects of tobacco smoking and electronic nicotine delivery systems on oral health – a narrative review. J Pre-Clin Clin Res 2022;16(3):118–25. DOI: 10.26444/jpccr/154648

28. Koo E.Y., Kozak K.J., Achim V., Wenig B.L. E-cigarette use and tobacco harm reduction: pilot survey study evaluating perspectives of head and neck surgeons. Head Neck 2022;44(2):582–5. DOI: 10.1002/hed.26949

29. Lindson N., Theodoulou A., Ordóñez-Mena J.M. et al. Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses. Cochrane Database Systemat Rev 2023;9(9):CD015226. DOI: 10.1002/14651858.CD015226.pub2

30. Lopukhov L.V., Laikov A.V., Salafutdinov I.I. et al. Investigation of the effects of acrolein and croton aldehyde in the Russian population during the transition from conventional cigarettes to an electronic tobacco heating system. Uchenye zapiski Kazanskogo universiteta. Seriya “Estestvennye nauki” = Scientific notes of Kazan University. The Natural Sciences series 2023;165(2): 190–203. (In Russ.). DOI: 10.26907/2542-064X.2023.2.190-203

31. Van Heest T., Rubin N., Khariwala S.S. Persistent tobacco use after treatment for head and neck cancer. JAMA Otolaryngol Head Neck Surg 2022;148(7):597–603. DOI: 10.1001/jamaoto.2022.0810